Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-24

Clinical Trial Update: Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of bosentan and sildenafil in Eisenmenger syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REVATIO (SILDENAFIL CITRATE)
  • TRACLEER (bosentan)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Eisenmenger Syndrome | Phase 3 | Status: COMPLETED